Proctitis causes rectal discomfort and bleeding. Learn what triggers it, how it's diagnosed, and which treatments actually ...

Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ:SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization, and rational therapeutic ...

New long-term extension data from the Phase IIb/III QUASAR trial demonstrate that Tremfya (guselkumab) maintains durable ...

Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrierData presented at Digestive Disease Week in San ...

Johnson & Johnson (NYSE: JNJ) today announced new data from the TREMFYA® (guselkumab) Phase 3 QUASAR long-term extension (LTE) study in adults with moderately-to-severely active ulcerative colitis (UC ...

Fintel reports that on May 8, 2025, Chardan Capital downgraded their outlook for Seres Therapeutics (NasdaqGS:MCRB) from Buy ...

Johnson & Johnson (J&J) has shared positive long-term results from a phase 3 trial of its dual-acting IL-23 inhibitor Tremfya ...

A new study finds that women with rheumatoid arthritis, lupus, or other autoimmune conditions have twice the risk of dying ...

Hunter Renfrow's treatment for ulcerative colitis caused him to take a hiatus from the NFL, the Carolina Panthers' new wide ...

The two major types of IBD―Crohn’s disease and ulcerative colitis―present with overlapping but distinct symptoms. Crohn’s ...

A RECENT study has explored the complex relationship between smoking and ulcerative colitis (UC), shedding light on how ...